Heterobifunctional Compounds as BRAF Degraders for Treating Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.2c00039
Abstract: proteasomal degradation. The present compounds to The present application describes a series of novel heterobifunctional as of for the the application read more here.
Keywords: degraders treating; chemistry; heterobifunctional compounds; treating cancer ... See more keywords